Skip to main content
Top
Published in: Clinical and Experimental Medicine 1/2017

01-02-2017 | Original Article

Osteopenia is associated with glycemic levels and blood pressure in Chinese postmenopausal women: a cross-sectional study

Authors: Qihong Sun, Yu Zheng, Kang Chen, Wenhua Yan, Juming Lu, Jingtao Dou, Zhaohui Lv, Baoan Wang, Weijun Gu, Jianming Ba, Yiming Mu

Published in: Clinical and Experimental Medicine | Issue 1/2017

Login to get access

Abstract

The aim of present study was to explore the relationships between osteopenia and dyslipidemia, glycemic levels or blood pressure in postmenopausal Chinese women. A total of 4080 women aged 42–85 years were enrolled in this cross-sectional study, which was nested in an ongoing longitudinal (REACTION) study. Calcaneus quantitative ultrasound (QUS) was performed and QUS T score was calculated to assess bone mineral density. Osteopenia was defined as a T score ≤−1.0. The relationship between osteopenia and dyslipidemia, glycemic levels or blood pressure was investigated. The prevalence of osteopenia was significantly lower in subjects with systolic blood pressure (SBP) ≥140 mmHg, fasting blood glucose (FBG) ≥8.0 mmol/L, postprandial blood glucose (PBG) ≥15.0 mmol/L, hemoglobin A1c (HbA1C) 6.5–7.5 %, HbA1C ≥7.5 %. These relationships remained significant after controlling for multiple factors. Moreover, significant trend between osteopenia and SBP, FBG, PBG and HbA1C was observed in women. In contrast, no significant associations between osteopenia and diastolic blood pressure (DBP), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) were found, and no significant trend relationship between osteopenia and DBP, TC, TG, HDL-C, LDL-C was found in postmenopausal Chinese women. The present study showed a relationship between SBP, FBG, PBG, HbA1C and osteopenia in postmenopausal Chinese women, while no significant relationship was observed between dyslipidemia, DBP and osteopenia, even after controlling for multiple confounding factors.
Literature
1.
go back to reference Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254–9.CrossRefPubMedPubMedCentral Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254–9.CrossRefPubMedPubMedCentral
2.
go back to reference Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4:368–81.CrossRefPubMed Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4:368–81.CrossRefPubMed
4.
go back to reference Ling X, Cummings SR, Mingwei Q, et al. Vertebral fractures in Beijing, China: the Beijing Osteoporosis Project. J Bone Miner Res. 2000;15:2019–25.CrossRefPubMed Ling X, Cummings SR, Mingwei Q, et al. Vertebral fractures in Beijing, China: the Beijing Osteoporosis Project. J Bone Miner Res. 2000;15:2019–25.CrossRefPubMed
5.
go back to reference Ning G. Risk evaluation of cAncers in Chinese diabeTic individuals: a lONgitudinal (REACTION) study. J Diabetes. 2012;4:172–3.CrossRefPubMed Ning G. Risk evaluation of cAncers in Chinese diabeTic individuals: a lONgitudinal (REACTION) study. J Diabetes. 2012;4:172–3.CrossRefPubMed
6.
go back to reference Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137–41.CrossRefPubMed Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137–41.CrossRefPubMed
7.
go back to reference Hanley DA, Brown JP, Tenenhouse A, et al. Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res. 2003;18:784–90.CrossRefPubMed Hanley DA, Brown JP, Tenenhouse A, et al. Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res. 2003;18:784–90.CrossRefPubMed
8.
go back to reference Lidfeldt J, Holmdahl L, Samsioe G, et al. The influence of hormonal status and features of the metabolic syndrome on bone density: a population-based study of Swedish women aged 50 to 59 years. The women’s health in the Lund area study. Metabolism. 2002;51:267–70.CrossRefPubMed Lidfeldt J, Holmdahl L, Samsioe G, et al. The influence of hormonal status and features of the metabolic syndrome on bone density: a population-based study of Swedish women aged 50 to 59 years. The women’s health in the Lund area study. Metabolism. 2002;51:267–70.CrossRefPubMed
9.
go back to reference Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet. 1999;354:971–5.CrossRefPubMed Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet. 1999;354:971–5.CrossRefPubMed
10.
go back to reference Mussolino ME, Gillum RF. Bone mineral density and hypertension prevalence in postmenopausal women: results from the Third National Health and Nutrition Examination Survey. Ann Epidemiol. 2006;16:395–9.CrossRefPubMed Mussolino ME, Gillum RF. Bone mineral density and hypertension prevalence in postmenopausal women: results from the Third National Health and Nutrition Examination Survey. Ann Epidemiol. 2006;16:395–9.CrossRefPubMed
11.
go back to reference Orwoll ES, Bevan L, Phipps KR. Determinants of bone mineral density in older men. Osteoporos Int. 2000;11:815–21.CrossRefPubMed Orwoll ES, Bevan L, Phipps KR. Determinants of bone mineral density in older men. Osteoporos Int. 2000;11:815–21.CrossRefPubMed
12.
go back to reference Woo J, Kwok T, Leung J, Tang N. Dietary intake, blood pressure and osteoporosis. J Hum Hypertens. 2009;23:451–5.CrossRefPubMed Woo J, Kwok T, Leung J, Tang N. Dietary intake, blood pressure and osteoporosis. J Hum Hypertens. 2009;23:451–5.CrossRefPubMed
13.
go back to reference Jeon YK, Lee JG, Kim SS, et al. Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women. Endocr J. 2011;58:87–93.CrossRefPubMed Jeon YK, Lee JG, Kim SS, et al. Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women. Endocr J. 2011;58:87–93.CrossRefPubMed
14.
go back to reference Chan KA, Andrade SE, Boles M, et al. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet. 2000;355:2185–8.CrossRefPubMed Chan KA, Andrade SE, Boles M, et al. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet. 2000;355:2185–8.CrossRefPubMed
15.
go back to reference Rejnmark L, Vestergaard P, Mosekilde L. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study. Calcif Tissue Int. 2006;79:27–36.CrossRefPubMed Rejnmark L, Vestergaard P, Mosekilde L. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study. Calcif Tissue Int. 2006;79:27–36.CrossRefPubMed
16.
go back to reference Kim YH, Nam GE, Cho KH, et al. Low bone mineral density is associated with dyslipidemia in South Korean men: the 2008–2010 Korean National Health and Nutrition Examination Survey. Endocr J. 2013;60:1179–89.CrossRefPubMed Kim YH, Nam GE, Cho KH, et al. Low bone mineral density is associated with dyslipidemia in South Korean men: the 2008–2010 Korean National Health and Nutrition Examination Survey. Endocr J. 2013;60:1179–89.CrossRefPubMed
17.
go back to reference Hernández JL, Olmos JM, Pariente E, et al. Metabolic syndrome and bone metabolism: the Camargo Cohort study. Menopause. 2010;17:955–61.CrossRefPubMed Hernández JL, Olmos JM, Pariente E, et al. Metabolic syndrome and bone metabolism: the Camargo Cohort study. Menopause. 2010;17:955–61.CrossRefPubMed
18.
go back to reference Kim YH, Cho KH, Choi YS, et al. Low bone mineral density is associated with metabolic syndrome in South Korean men but not in women: the 2008–2010 Korean National Health and Nutrition Examination Survey. Arch Osteoporos. 2013;8:142. doi:10.1007/s11657-013-0142-3.CrossRefPubMed Kim YH, Cho KH, Choi YS, et al. Low bone mineral density is associated with metabolic syndrome in South Korean men but not in women: the 2008–2010 Korean National Health and Nutrition Examination Survey. Arch Osteoporos. 2013;8:142. doi:10.​1007/​s11657-013-0142-3.CrossRefPubMed
19.
go back to reference Arikan DC, Coskun A, Ozer A, Kilinc M, Atalay F, Arikan T. Plasma selenium, zinc, copper and lipid levels in postmenopausal Turkish women and their relation with osteoporosis. Biol Trace Elem Res. 2011;144:407–17.CrossRefPubMed Arikan DC, Coskun A, Ozer A, Kilinc M, Atalay F, Arikan T. Plasma selenium, zinc, copper and lipid levels in postmenopausal Turkish women and their relation with osteoporosis. Biol Trace Elem Res. 2011;144:407–17.CrossRefPubMed
20.
go back to reference Yaturu S, Humphrey S, Landry C, Jain SK. Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes. Med Sci Monit. 2009;15:CR5–9.PubMed Yaturu S, Humphrey S, Landry C, Jain SK. Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes. Med Sci Monit. 2009;15:CR5–9.PubMed
21.
go back to reference Petit MA, Paudel ML, Taylor BC, et al. Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J Bone Miner Res. 2010;25:285–91.CrossRefPubMed Petit MA, Paudel ML, Taylor BC, et al. Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J Bone Miner Res. 2010;25:285–91.CrossRefPubMed
22.
go back to reference Yamaguchi T, Kanazawa I, Yamamoto M, et al. Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Bone. 2009;45:174–9.CrossRefPubMed Yamaguchi T, Kanazawa I, Yamamoto M, et al. Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Bone. 2009;45:174–9.CrossRefPubMed
Metadata
Title
Osteopenia is associated with glycemic levels and blood pressure in Chinese postmenopausal women: a cross-sectional study
Authors
Qihong Sun
Yu Zheng
Kang Chen
Wenhua Yan
Juming Lu
Jingtao Dou
Zhaohui Lv
Baoan Wang
Weijun Gu
Jianming Ba
Yiming Mu
Publication date
01-02-2017
Publisher
Springer International Publishing
Published in
Clinical and Experimental Medicine / Issue 1/2017
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-015-0397-7

Other articles of this Issue 1/2017

Clinical and Experimental Medicine 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.